Lindner Center of HOPE News

Dr. Susan McElroy comments on results from a 24-week open-label study of Contrave

July 1, 2010
Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX) today announced results from a 24-week open-label study demonstrating that treatment with Contrave(R) resulted in significant improvements in depressive symptoms that was accompanied by weight loss and improved control of eating in overweight and obese patients with major depression. Mason, OH – July 1, 2010– “This study is the first […]

Lindner Center of HOPE offers TMS Therapy, an innovative, new treatment option for depression

September 1, 2009
Mason, OH –September 2009 – Lindner Center of HOPE introduced a groundbreaking new treatment for patients with major depression beginning in August 2009. Transcranial Magnetic Stimulation (TMS) is a non-invasive treatment that uses electromagnetic energy to stimulate the area of the brain that is linked to depression. As a charter member of the National Network […]